Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217126 · ClinicalTrials.gov registry record
The Study of Long-term Deterioration of Kidney Transplants.
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 870
- Enrollment target
NCT00217126: Completed study, sponsored by Mayo Clinic.
NCT00217126 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 870 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00217126 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 870 participants
- Enrollment target
Study Summary
This study is being done to create a kidney transplant database with information from many transplant centers for the purpose of studying ways to help improve transplant outcomes and the care of transplant recipients. This is also being done to learn why kidney transplant recipients have worsening of their kidney function, and whether there are specific findings that could result in future treatments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 870 participants |
| Start Date | 2005-10 |
| Est. Completion | 2012-08 |
What the finished NCT00217126 record still lists
NCT00217126 is an observational study that tracks outcomes without assigning an intervention. The registered 870 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00217126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00217126 about?
NCT00217126 is a clinical study titled "The Study of Long-term Deterioration of Kidney Transplants.". This study is being done to create a kidney transplant database with information from many transplant centers for the purpose of studying ways to help improve transplant outcomes and the care of transplant recipients. This is also being done to learn why kidney transplant recipients have worsening o...
What is the current status of trial NCT00217126?
This trial is currently completed. The enrollment target is 870 participants. The study started on 2005-10. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT00217126?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04097145 · 870 participants · NA
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- NCT06822790 · 869 participants · Phase 3
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- NCT06077760 · 868 participants · Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- NCT04933552 · 867 participants
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia